Back to results
US 2019/0167650 A1Published application
Methods of treating pancreatic cancer
AssigneeChemoCentryx, Inc.
InventorsPetrus Bekker, Shichang Miao, Israel Charo, Tom Schall
Life of this patent
Estimating the term…
Abstract
The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.
Claims21
1-86. (canceled)
A method of limiting over-expression of oncogenes, activating tumor suppressor genes, or regulating signaling proteins comprising administering to a patient in need thereof an effective amount of a compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is halogen or C1-6 alkyl;
- R2 is hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C1-6 haloalkoxy, or —CN;
- R3 is hydrogen, halogen, or C1-6 alkyl;
- R4 is hydrogen, halogen, or C1-6 alkyl;
- each R5 is independently C1-6 alkyl, —OH, or —NH2;
- n is 0, 1, 2, or 3;
- and
- each of A1, A2, and A3 is —CH— or —N—, where at least one of A1, A2, or A3 is —N—.
6 more elements
Dependencies are inferred from the claim text.